Obesity:体重正常但腰粗 ,更易患痴呆症

2019-11-08 佚名 医学新视点

痴呆症影响全世界约5000万人,每年有近1000万新发病例。世界卫生组织发布的《降低认知衰退和痴呆症风险指南》提出,超重和肥胖是痴呆症的危险因素。体重指数(BMI)是衡量是否肥胖的重要指标,不过根据一项新的研究,腰围(WC)相比于BMI,更能反映腹部内脏脂肪水平。

痴呆症影响全世界约5000万人,每年有近1000万新发病例。世界卫生组织发布的《降低认知衰退和痴呆症风险指南》提出,超重和肥胖是痴呆症的危险因素。体重指数(BMI)是衡量是否肥胖的重要指标,不过根据一项新的研究,腰围(WC)相比于BMI,更能反映腹部内脏脂肪水平。

一项发表在肥胖学会官方期刊Obesity的大规模队列研究显示,在老年人群体中,体重正常但腹型肥胖的人,相比于没有腹部肥胖的人,患痴呆症的风险显着增加。

研究人员对超过87万名受试者进行了随访研究,他们的年龄在65岁及以上,并在2009年1月1日至2009年12月31日参加了韩国国家健康筛查。研究人员对他们随访直至发展为痴呆症、死亡或2015年12月31日随访结束,平均随访达6.5年。腹型肥胖的标准为男性腰围 ≥90cm,女性腰围≥85m。

在随访期间,有114024位受试者被诊断出痴呆症。在调整了其他变量因素后,如年龄、BMI、生活方式、经济状况及各种心血管疾病风险,研究人员发现,整体而言,在腹型肥胖的人群中,痴呆症风险随着腰围的增加而增加。比如,腰围≥110cm,男性和女性痴呆症风险分别增加63%和58%。

而BMI的影响则似乎相反。相较于BMI正常的人群,体重偏轻的老年男性和女性痴呆症风险分别升高21%和26%,超重和肥胖人群则风险较低。

为何会有截然相反的发现?研究人员又进一步分析了腹型肥胖(即腰围)和全身体重的综合影响。统计显示,对于体重正常的腹型肥胖者,患痴呆症的风险仍然显着增加,男性增加了15%,女性增加了23%;不过在按BMI属于超重和肥胖的腹型肥胖者中,患痴呆症的风险显着降低。这表明,腰围对痴呆症风险的影响,可能因个人的BMI不同而有区别。

科罗拉多大学(University of Colorado School)医学院Dan Bessesen博士认为:“该研究可能指出了皮下脂肪与腹部脂肪在痴呆症发展中的不同作用,皮下脂肪具有保护作用,腹部脂肪则有害。而BMI与痴呆症的关联,可能更多反映了老年人群的‘瘦’体重,老年人群BMI偏低可能是肌肉流失的表现。”

该研究通讯作者、韩国高丽大学(Korea University)九老医院副教授Hye Jin Yoo表示:“这项研究强调,在评估老年人与肥胖相关的痴呆风险时,应考虑腰围。”

腰粗的风险在众多研究中都有所体现。剑桥大学(university of cambridge)的一项研究显示,脂肪堆积在内脏器官或血液中的人,更容易得2型糖尿病和心血管疾病,而这两方面也都是痴呆症的风险因素。这项研究再次提醒我们,低头看看,谨防肚子上长太多肉。

原始出处:
Cho GJ1, Hwang SY2, Lee KM3, et al.Association Between Waist Circumference and Dementia in Older Persons: A Nationwide Population-Based Study.Obesity (Silver Spring). 2019 Nov;27(11):1883-1891. doi: 10.1002/oby.22609.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1836208, encodeId=e6461836208b7, content=<a href='/topic/show?id=4613e1212fc' target=_blank style='color:#2F92EE;'>#痴呆症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71212, encryptionId=4613e1212fc, topicName=痴呆症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=726030, createdName=Boyinsh, createdTime=Sun Apr 26 21:32:00 CST 2020, time=2020-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1910528, encodeId=d9301910528c2, content=<a href='/topic/show?id=faf7163606a' target=_blank style='color:#2F92EE;'>#SIT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16360, encryptionId=faf7163606a, topicName=SIT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e6a1280, createdName=zhanglin3079, createdTime=Mon Sep 28 10:32:00 CST 2020, time=2020-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1461774, encodeId=fc321461e7486, content=<a href='/topic/show?id=92c2132003b' target=_blank style='color:#2F92EE;'>#Obesity#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13200, encryptionId=92c2132003b, topicName=Obesity)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45616444603, createdName=lingaifan, createdTime=Sun Nov 10 04:32:00 CST 2019, time=2019-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1588396, encodeId=cc1f1588396f7, content=<a href='/topic/show?id=1cb8e014e0' target=_blank style='color:#2F92EE;'>#ESI#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7014, encryptionId=1cb8e014e0, topicName=ESI)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=智者为医08, createdTime=Sun Nov 10 04:32:00 CST 2019, time=2019-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1048571, encodeId=2f9510485e1f9, content=老年人痴呆何药可用??, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=junJUN, createdTime=Fri Nov 08 16:32:00 CST 2019, time=2019-11-08, status=1, ipAttribution=)]
    2020-04-26 Boyinsh
  2. [GetPortalCommentsPageByObjectIdResponse(id=1836208, encodeId=e6461836208b7, content=<a href='/topic/show?id=4613e1212fc' target=_blank style='color:#2F92EE;'>#痴呆症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71212, encryptionId=4613e1212fc, topicName=痴呆症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=726030, createdName=Boyinsh, createdTime=Sun Apr 26 21:32:00 CST 2020, time=2020-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1910528, encodeId=d9301910528c2, content=<a href='/topic/show?id=faf7163606a' target=_blank style='color:#2F92EE;'>#SIT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16360, encryptionId=faf7163606a, topicName=SIT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e6a1280, createdName=zhanglin3079, createdTime=Mon Sep 28 10:32:00 CST 2020, time=2020-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1461774, encodeId=fc321461e7486, content=<a href='/topic/show?id=92c2132003b' target=_blank style='color:#2F92EE;'>#Obesity#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13200, encryptionId=92c2132003b, topicName=Obesity)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45616444603, createdName=lingaifan, createdTime=Sun Nov 10 04:32:00 CST 2019, time=2019-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1588396, encodeId=cc1f1588396f7, content=<a href='/topic/show?id=1cb8e014e0' target=_blank style='color:#2F92EE;'>#ESI#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7014, encryptionId=1cb8e014e0, topicName=ESI)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=智者为医08, createdTime=Sun Nov 10 04:32:00 CST 2019, time=2019-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1048571, encodeId=2f9510485e1f9, content=老年人痴呆何药可用??, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=junJUN, createdTime=Fri Nov 08 16:32:00 CST 2019, time=2019-11-08, status=1, ipAttribution=)]
    2020-09-28 zhanglin3079
  3. [GetPortalCommentsPageByObjectIdResponse(id=1836208, encodeId=e6461836208b7, content=<a href='/topic/show?id=4613e1212fc' target=_blank style='color:#2F92EE;'>#痴呆症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71212, encryptionId=4613e1212fc, topicName=痴呆症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=726030, createdName=Boyinsh, createdTime=Sun Apr 26 21:32:00 CST 2020, time=2020-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1910528, encodeId=d9301910528c2, content=<a href='/topic/show?id=faf7163606a' target=_blank style='color:#2F92EE;'>#SIT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16360, encryptionId=faf7163606a, topicName=SIT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e6a1280, createdName=zhanglin3079, createdTime=Mon Sep 28 10:32:00 CST 2020, time=2020-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1461774, encodeId=fc321461e7486, content=<a href='/topic/show?id=92c2132003b' target=_blank style='color:#2F92EE;'>#Obesity#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13200, encryptionId=92c2132003b, topicName=Obesity)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45616444603, createdName=lingaifan, createdTime=Sun Nov 10 04:32:00 CST 2019, time=2019-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1588396, encodeId=cc1f1588396f7, content=<a href='/topic/show?id=1cb8e014e0' target=_blank style='color:#2F92EE;'>#ESI#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7014, encryptionId=1cb8e014e0, topicName=ESI)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=智者为医08, createdTime=Sun Nov 10 04:32:00 CST 2019, time=2019-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1048571, encodeId=2f9510485e1f9, content=老年人痴呆何药可用??, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=junJUN, createdTime=Fri Nov 08 16:32:00 CST 2019, time=2019-11-08, status=1, ipAttribution=)]
    2019-11-10 lingaifan
  4. [GetPortalCommentsPageByObjectIdResponse(id=1836208, encodeId=e6461836208b7, content=<a href='/topic/show?id=4613e1212fc' target=_blank style='color:#2F92EE;'>#痴呆症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71212, encryptionId=4613e1212fc, topicName=痴呆症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=726030, createdName=Boyinsh, createdTime=Sun Apr 26 21:32:00 CST 2020, time=2020-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1910528, encodeId=d9301910528c2, content=<a href='/topic/show?id=faf7163606a' target=_blank style='color:#2F92EE;'>#SIT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16360, encryptionId=faf7163606a, topicName=SIT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e6a1280, createdName=zhanglin3079, createdTime=Mon Sep 28 10:32:00 CST 2020, time=2020-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1461774, encodeId=fc321461e7486, content=<a href='/topic/show?id=92c2132003b' target=_blank style='color:#2F92EE;'>#Obesity#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13200, encryptionId=92c2132003b, topicName=Obesity)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45616444603, createdName=lingaifan, createdTime=Sun Nov 10 04:32:00 CST 2019, time=2019-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1588396, encodeId=cc1f1588396f7, content=<a href='/topic/show?id=1cb8e014e0' target=_blank style='color:#2F92EE;'>#ESI#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7014, encryptionId=1cb8e014e0, topicName=ESI)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=智者为医08, createdTime=Sun Nov 10 04:32:00 CST 2019, time=2019-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1048571, encodeId=2f9510485e1f9, content=老年人痴呆何药可用??, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=junJUN, createdTime=Fri Nov 08 16:32:00 CST 2019, time=2019-11-08, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1836208, encodeId=e6461836208b7, content=<a href='/topic/show?id=4613e1212fc' target=_blank style='color:#2F92EE;'>#痴呆症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71212, encryptionId=4613e1212fc, topicName=痴呆症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=726030, createdName=Boyinsh, createdTime=Sun Apr 26 21:32:00 CST 2020, time=2020-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1910528, encodeId=d9301910528c2, content=<a href='/topic/show?id=faf7163606a' target=_blank style='color:#2F92EE;'>#SIT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16360, encryptionId=faf7163606a, topicName=SIT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e6a1280, createdName=zhanglin3079, createdTime=Mon Sep 28 10:32:00 CST 2020, time=2020-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1461774, encodeId=fc321461e7486, content=<a href='/topic/show?id=92c2132003b' target=_blank style='color:#2F92EE;'>#Obesity#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13200, encryptionId=92c2132003b, topicName=Obesity)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45616444603, createdName=lingaifan, createdTime=Sun Nov 10 04:32:00 CST 2019, time=2019-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1588396, encodeId=cc1f1588396f7, content=<a href='/topic/show?id=1cb8e014e0' target=_blank style='color:#2F92EE;'>#ESI#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7014, encryptionId=1cb8e014e0, topicName=ESI)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=智者为医08, createdTime=Sun Nov 10 04:32:00 CST 2019, time=2019-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1048571, encodeId=2f9510485e1f9, content=老年人痴呆何药可用??, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=junJUN, createdTime=Fri Nov 08 16:32:00 CST 2019, time=2019-11-08, status=1, ipAttribution=)]
    2019-11-08 junJUN

    老年人痴呆何药可用??

    0

相关资讯

Science:揭秘体重增加的“幕后”:代谢、吸脂的昼夜节律,竟然由肠道菌掌控...

肠道微生物,小身材,大作用!无时无刻都在影响着我们的健康。近日,一项研究发现,这些生活在哺乳动物肠道的细菌,还支配者体内脂质(脂肪)吸收的代谢节律。

JAHA:T2DM患者减重后体重恢复,会削弱心血管获益

最近的研究表明,体重减轻的2型糖尿病(T2M)患者发生心血管疾病的风险较低。但是,如果一段时间后他们的体重反弹了,心血管获益会随之消散吗?

ESC2019丨青年男子体重增加与65岁前心肌梗死风险相关

编者按:在刚刚结束的ESC 2019大会上,瑞典哥德堡大学Maria Aberg博士发布一项针对近170万名18岁男孩的研究发现,体重指数(BMI)越高,65岁前心肌梗死风险就越大。这提示,肥胖问题应引起重视,适当控制体重。

Nat Med: 年纪越大体重越难控制,新研究揭示背后原因

许多人都在努力控制自己的体重。然而,随着年龄的增长,减轻体重变得越来越困难,甚至身边经常有人抱怨,喝水发胖,连呼吸都会变胖。太难了,减肥真的太难了。那这到底是为什么?

BMJ:成年后体重变化与死亡风险

研究认为,整个成年期的稳定肥胖、从年轻到成的体重增加以及从中年到晚年的体重减轻与死亡率的增加有关。研究结果表明,在成年后维持正常体重,特别是在成年早期预防体重增加对降低死亡风险有显著作用

Hypertension:高血压持续时间和程度以及体重对新发房颤的影响

总之,高血压的程度和持续时间以及高血压的存在是新发AF的重要因素。体重状态与新发AF显著相关,并与高血压具有协同作用。